Journal profile

Journal of the American Heart Association

Publisher: Wiley-Blackwell
ISSN2047-9980 FormatOnline StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.61
Citation rate 6.63 14,570 total citations
h5-index 97 h5 depth signal
Cited share 88.4% 2,048 of 2,316
Total citations 14,570 Citation footprint
Metric signal 6.66 External metric anchor
Self-citation 2.4% 347 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 6,245
China 1,720
United Kingdom 969
Canada 859
Japan 783

Citing Fields of Research

Cardiology 7,647
Vascular Disorders 1,452
Diabetes 778
Autonomic Function 626
Lipids 614

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 12,810 Articles tracked across the journal lifetime
Indexed publication set 2,316 2,048 cited publications
Last 12 months 1,350 112.5 publications/month
Open access share 78.1% 1,054 OA publications in the last year
Leading citing country United States 6,245 citing publications
Leading citing field Cardiology 7,647 citing publications
Latest tracked publication 16 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, Feb. 2012-
PubMed
v1n1, Feb. 2012-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Cardiology

Issuing & Sponsoring Bodies

Contributor
American Heart Association
Contributor
American Stroke Association

Broad Categories

Cardiology Vascular Diseases

MeSH Descriptors

Cardiology Cardiovascular Diseases Cerebrovascular Disorders Heart Diseases

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

02
Bo Shao, Ruoxi Zhang, Jie Guo et al.
Background: Coronary computed tomography (CT) angiography with CT‐derived fractional flow reserve (CT‐FFR) enables noninvasive identification of flow‐limiting coronary stenosis and is widely used for risk assessment. However, adverse car...
03
Marco Zuin, Claudio Bilato, Gianluca Rigatelli et al.
Background: Patients with atherosclerotic cardiovascular disease (ASCVD) are at increased risk of pulmonary embolism (PE) and related mortality, yet contemporary US trends remain incompletely defined. We examined PE‐attributable mortalit...
04
Aidan M. Kirkham, Jasmine Candeliere, Justin Presseau et al.
Background: We sought to determine the effectiveness of discrete strategies and implementation bundles for improving clinical practice guideline (CPG) strongly recommended medication prescription to adults with atherosclerotic occlusive ...
05
Parveen K. Garg, Weihua Guan, Sarah Nomura et al.
Background: Higher plasma glycoprotein acetylation (GlycA) concentrations are associated with an increased risk for incident cardiovascular disease (CVD). We investigated the combined associations of GlycA with lipoprotein (a) (Lp[a]) an...
07
Danilo Malandrino, Alessandra Bettiol, Alessandro Andreis et al.
Background: Anakinra is effective in recurrent pericarditis, yet optimal treatment duration and strategies for safe drug discontinuation remain uncertain. Identifying predictors of sustained remission after discontinuation is important f...
09
Milagros Galecio‐Castillo, Aaron Rodriguez‐Calienes, Leonardo Cruz‐Criollo et al.
Background: Optimal anticoagulation in acute cerebral vein thrombosis remains uncertain. We compared unfractionated heparin (UFH) and enoxaparin, and identified predictors of functional recovery and UFH responsiveness. Methods: This retr...